Bildkälla: Stockfoto

Scandion Oncology: Outcome of right issue announced - Redeye

Redeye comments on the outcome of Scandion’s rights issue, and we resume our coverage. We adjust our valuation for increased cash and shares outstanding.

Redeye comments on the outcome of Scandion’s rights issue, and we resume our coverage. We adjust our valuation for increased cash and shares outstanding.
Börsvärldens nyhetsbrev
ANNONSER